Literature DB >> 1969874

Anti-CD3 antibodies induce T cells from unprimed animals to secrete IL-4 both in vitro and in vivo.

V Flamand1, D Abramowicz, M Goldman, C Biernaux, G Huez, J Urbain, M Moser, O Leo.   

Abstract

Recently, functional heterogeneity among Th cells has been recognized. Based on pattern of lymphokine secretion, two mutually exclusive subsets of CD4+ cells have been defined and designated Th1 (secreting IL-2 and IFN-gamma) and Th2 (secreting IL-4 and IL-5). Identification of these subsets was mostly based on the study of long term cultured T cell lines and clones, and little is known about the Th heterogeneity in vivo. In particular, it has been suggested that IL-4 producing cells cannot be detected in vivo or in primary stimulations in vitro unless responder cells had been previously primed. Our data however, indicate that anti-CD3 mediated stimulation can induce T cells isolated from unprimed animals to IL-4 production. An assay system based on the ability of IL-4 to increase Ia expression of B cells present in the environment of activated T cells was found to be more sensitive than detection of secreted IL-4 in the supernatant by conventional bioassays and was used to study IL-4 production by unprimed lymphocytes polyclonally stimulated in vivo and in vitro by anti-CD3 mAb. The results obtained indicate that CD4+ CD8- T cells able to produce IL-4 upon receptor-specific stimulation exist in the preimmune pool of adult animals. Remarkably, these cells can also be stimulated in vivo by treating animals with anti-CD3 mAb, as indicated by the in vivo induction of IL-4 specific mRNA and hyper-Ia expression on B cells. These results indicate that the inability to detect IL-4 in primary cultures is not due to different activation requirements of Th2 cells but may simply result from their lower frequency in unprimed animals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969874

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  11 in total

Review 1.  Induction of T helper cell subsets.

Authors:  M Röcken; K M Müller; C Hauser
Journal:  Springer Semin Immunopathol       Date:  1992

2.  T-helper 1-like subset selection in Mycobacterium bovis bacillus Calmette-Guérin-infected resistant and susceptible mice.

Authors:  I Kramnik; D Radzioch; E Skamene
Journal:  Immunology       Date:  1994-04       Impact factor: 7.397

3.  Allergen-dependent induction of interleukin-4 synthesis in vivo.

Authors:  X Yang; K T Hayglass
Journal:  Immunology       Date:  1993-01       Impact factor: 7.397

4.  Efficient targeting of the IL-4 gene in a BALB/c embryonic stem cell line.

Authors:  N Noben-Trauth; G Köhler; K Bürki; B Ledermann
Journal:  Transgenic Res       Date:  1996-11       Impact factor: 2.788

5.  Differential regulation by phorbol myristate acetate of IFN-gamma and IL-4 expression in anti-CD3 stimulated mouse spleen cells.

Authors:  P Monteyne; J C Renauld; J P Coutelier
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

Review 6.  Immunomodulation of transplant rejection using monoclonal antibodies and soluble receptors.

Authors:  M L Alegre; D J Lenschow; J A Bluestone
Journal:  Dig Dis Sci       Date:  1995-01       Impact factor: 3.199

7.  Antibody responses to a cytochrome c peptide do not correlate with lymphokine production patterns from helper T-cell subsets.

Authors:  B S Fox
Journal:  Immunology       Date:  1992-01       Impact factor: 7.397

8.  Antigen-specific activation, tolerization, and reactivation of the interleukin 4 pathway in vivo.

Authors:  M Röcken; J Urban; E M Shevach
Journal:  J Exp Med       Date:  1994-06-01       Impact factor: 14.307

9.  CD4pos, NK1.1pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3.

Authors:  T Yoshimoto; W E Paul
Journal:  J Exp Med       Date:  1994-04-01       Impact factor: 14.307

10.  In vivo induction of interleukin 10 by anti-CD3 monoclonal antibody or bacterial lipopolysaccharide: differential modulation by cyclosporin A.

Authors:  P Durez; D Abramowicz; C Gérard; M Van Mechelen; Z Amraoui; C Dubois; O Leo; T Velu; M Goldman
Journal:  J Exp Med       Date:  1993-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.